Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Cytlimic
company
About
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine.
- Higashi-shinagawa,Tokyo,Japan
- 1 - 10
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Dec 16, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Cytlimic Inc.
CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC’s products aim to activate immune systems to attack cancer cells while enabling patients to maintain a high quality-of-life during treatment.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥2.30B
Cytlimic has raised a total of
¥2.30B
in funding over 2 rounds. Their latest funding was raised on
Aug 9, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 9, 2019 | Series B | ¥1.30B | 3 | — | — | Detail |
| Dec 27, 2016 | Seed | — | 1 | — | — | Detail |
| Dec 19, 2016 | Series A | ¥1B | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Cytlimic is funded by 3 investors.
Fast Track Initiative, Inc.
and NEC Capital Solutions
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Fast Track Initiative, Inc.
|
— | Series B |
NEC Capital Solutions
|
— | Series B |
SMBC Venture Capital
|
— | Series B |
Employee Profiles
Number of Employee Profiles
7
Cytlimic has 7 current employee profiles, including
Board member Hiromichi Kimura
Board member
Board member
Executive
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
